Physician profile
Eva Toth
NPI 1417985680
$23,438.74
in general payments reported to CMS, 2019-2025
59 companies · $2,427 in 2025
The $2,427 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,893 · 2020: $3,343 · 2021: $3,577 · 2022: $3,489 · 2023: $3,099 · 2024: $2,610 · 2025: $2,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,117 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,116.63 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $3,074.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $2,076.68 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Medtronic Minimed, INC. | $1,983.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,633.01 | 2019-2025 | Jardiance, Tradjenta, Glyxambi |
| Amarin Pharma, INC. | $1,459.05 | 2019-2023 | |
| Amneal Pharmaceuticals LLC | $1,437.02 | 2019-2025 | Unithroid |
| Astrazeneca Pharmaceuticals Lp | $1,293.74 | 2019-2023 | Farxiga |
| Medtronic, INC. | $1,044.94 | 2021-2025 | Inpen Smart Insulin Delivery System, Minimed 780g |
| Amgen INC. | $911.64 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $837.84 | 2019-2025 | |
| Dexcom, INC. | $785.62 | 2019-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $601.39 | 2019-2024 | Korlym |
| Becton, Dickinson and Company | $545.92 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $494.80 | 2021-2025 | |
| Abbott Laboratories | $461.52 | 2019-2025 | Freestyle Libre 3, Proclaim, Freestyle Libre 2 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $460.52 | 2019-2025 | Synthroid |
| Cequr Corporation | $453.75 | 2022-2025 | Cequr Simplicity |
| Amphastar Pharmaceuticals, INC. | $417.79 | 2024-2025 | |
| Esperion Therapeutics, INC. | $312.93 | 2020-2025 | Nexletol |
| Embecta Corp. | $183.53 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Xeris Pharmaceuticals, INC. | $168.51 | 2021-2025 | Gvoke Hypopen |
| Pfizer INC. | $162.98 | 2019-2024 | |
| Ascendis Pharma Endocrinology INC | $159.19 | 2023-2025 | Yorvipath |
| Insulet Corporation | $153.76 | 2019-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $150.71 | 2021-2025 | Strensiq |
| Merck Sharp & Dohme LLC | $144.45 | 2019-2025 | Welireg |
| Antares Pharma, INC. | $141.20 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Radius Health, INC. | $139.98 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $129.84 | 2019 | |
| Neurocrine Biosciences, INC. | $110.42 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $107.46 | 2022-2024 | |
| Ultragenyx Pharmaceutical INC. | $102.55 | 2021-2024 | Crysvita, Crysvita |
| Nevro Corp. | $99.20 | 2022-2023 | Senza |
| Madrigal Pharmaceuticals | $98.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Soleno Therapeutics, INC. | $94.63 | 2025 | Vykat Xr |
| Recordati_rare_diseases_inc. | $89.63 | 2021-2023 | Signifor Lar, Isturisa |
| Ibsa Pharma INC. | $78.35 | 2019-2023 | Tirosint, Licart |
| Janssen Pharmaceuticals, INC | $68.42 | 2019-2020 | |
| Averitas Pharma INC. | $67.62 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $67.36 | 2019-2022 | |
| Amryt Pharma Holdings Ltd | $59.25 | 2022-2023 | Mycapssa |
| Lifescan, INC. | $57.85 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $48.33 | 2019-2020 | |
| Halozyme INC | $45.74 | 2023 | |
| Verity Pharmaceuticals INC. | $39.91 | 2024-2025 | Tlando |
| Shire North American Group INC | $39.80 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $38.90 | 2019 | |
| Beta Bionics, INC. | $38.46 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kyowa Kirin, INC. | $34.47 | 2024-2025 | Crysvita |
| Kowa Pharmaceuticals America, INC. | $33.81 | 2019-2021 | |
| Tandem Diabetes Care, INC. | $31.90 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Aytu Biopharma, INC. | $30.23 | 2019 | |
| Sequel Med Tech, LLC | $25.16 | 2025 | Twiist |
| Rhythm Pharmaceuticals, INC. | $23.82 | 2025 | Imcivree |
| Almatica Pharma LLC | $20.72 | 2025 | Teriparatide |
| Valeritas, INC. | $20.21 | 2019 | |
| Zealand Pharma US, INC. | $17.15 | 2021 | |
| Theracosbio, LLC | $14.81 | 2024 | Brenzavvy |
| Takeda Pharmaceuticals U.S.A., INC. | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Toth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.